← Back
$LGND All transactions

LIGAND PHARMACEUTICALS INC

▼ SELL

$ Value

$418K

Shares

2,034

Price

$205

Filed

Nov 12

Insider

Name

LAMATTINA JOHN L

Title

CIK

0001216074

Roles

Director

Transaction Details

Transaction Date

2025-11-07

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

30,724

Footnotes

This Option was previously reported as a Grant of 2,456 shares, which vested in full on May 25, 2018, at an exercise price of $113.5000 per share but was adjusted pursuant to the OmniAb Inc. separation from the issuer. | This Option was previously reported as a Grant of 2,329 shares, which vested in full on May 23, 2017, at an exercise price of $119.3000 per share but was adjusted pursuant to the OmniAb Inc. separation from the issuer.

Filing Info

Accession No.

0002001011-25-000097

Form Type

4

Issuer CIK

0000886163

LAMATTINA JOHN L's History

Date Ticker Type Value
2026-03-06 LGND M $247K
2026-03-06 LGND $434K
2026-03-06 LGND M $0
2025-11-07 LGND M $142K
2025-11-07 LGND $441K
2025-11-07 LGND M $141K
2025-11-07 LGND $418K
2025-11-07 LGND M $0
2025-11-07 LGND M $0
2025-06-06 LGND A $0

Other Insiders at LGND (90d)

Insider Bought Sold Last
LAMATTINA JOHN L $434K 2026-03-06
KOZARICH JOHN W $94K 2026-04-01
Davis Todd C
Chief Executive Officer
2026-03-02
Sabba Stephen L $208K 2026-03-23
Espinoza Octavio
Chief Financial Officer
2026-03-02
Reardon Andrew
CLO & Secretary
$1.0M 2026-04-01